Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $9.75 Analyst target: $17.11 Upside: 75.49%
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in Needham, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.